A rapidly developing field in imaging is the characterization, engineering and discovery of new contrast agents for a wide variety of needs such as multimodal imaging, cell tracking and targeted drug delivery. Our facility offers several noninvasive in vivo imaging systems to be used with contrast agents: ASPECT 1T MRI, Bruker BioSpec 9.4T MRI and Vevo 2100 Ultrasound. These systems enable contrast agent characterization both in vitro and in vivo. The IVIS 200 Optical Imaging system provides an additional platform to validate the existence of luminance/fluorescence contrast agent distribution.
Our facility also offers quantitative techniques to support and validate the in vivo imaging results. Read about whole slice imaging at Slide Scanner.